Trials / Recruiting
RecruitingNCT05522218
Eluvia DES for the Patients with Femoropopliteal Artery Lesions.
Clinical Effectiveness and Health Economic Evaluation of Eluvia Drug-eluting Stent in the Treatment of Femoropopliteal Artery Lesions
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study is a multicenter, prospective, observational study, aiming to enroll 400 patients with peripheral arterial disease in the femoral-popliteal segment implanted with Eluvia stent. Each patient was followed up for 2 years. The technical success rate, target lesion patency rate, quality of life improvement, cost of Eluvia stent implantation, and other outcomes will be analysed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Eluvia drug eluting stent | Eluvia drug eluting stent for peripheral arterial disease |
Timeline
- Start date
- 2022-08-01
- Primary completion
- 2025-08-01
- Completion
- 2025-12-31
- First posted
- 2022-08-30
- Last updated
- 2024-09-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05522218. Inclusion in this directory is not an endorsement.